We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleREO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors.AuthorsMorris, Don; Feng, Xiaolan; DiFrancesco, Lisa; Fonseca, Kevin; Forsyth, Peter; Paterson, Alexander; Coffey, Matt; Thompson, BradPublicationInvestigational New Drugs, 2013, Vol 31, Issue 3, p696ISSN0167-6997Publication typearticleDOI10.1007/s10637-012-9865-z